#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia recurrent Kawasaki's disease Oesophageal adenocarcinoma stage II Acute myeloid leukaemia refractory Fusarium infection Acute promyelocytic leukaemia Pulmonary sarcoidosis Lennox-Gastaut syndrome Congenital cystic kidney disease Dedifferentiated liposarcoma Arrhythmia Complex regional pain syndrome Squamous cell carcinoma of the hypopharynx Pituitary-dependent Cushing's syndrome Progressive supranuclear palsy More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer Loeys-Dietz syndrome – Life with Disease Myelodysplastic syndrome – Basic Information Rhabdomyosarcoma recurrent – Diagnostics Glycogen storage disease type V – Life with Disease Testicular leiomyosarcoma – Treatment Andersen-Tawil syndrome – Life with Disease Primary immunodeficiency syndrome – Life with Disease CADASIL – Treatment Synovial sarcoma recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Volixibat Cinchocaine Hydrochloride MAPLIRPACEPT Pilocarpine Nitrate Binimetinib GSKVX000000034794 Eletriptan N-Acetylhistidine GSKVX000000039711 Pritelivir Azetukalner Volrustomig Thiamine Nitrate Bp Emiplacel Goserelin Cobolimab Naloxone Hydrochloride Ciclesonide Bezafibrate Human Coagulation Factor X More therapies…

    Learn about Your Condition

    Retroperitoneal fibrosis Osteosarcoma metastatic Colon cancer Neuropathic arthropathy Liposarcoma recurrent Cardiac ventricular thrombosis Immune-mediated renal disorder Vulvovaginal discomfort Takayasu's arteritis Peritoneal abscess Plasma cell myeloma Muscle injury Partial lipodystrophy Adenocarcinoma pancreas Measles More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Safety and dose‑finding study of trazodone hydrochloride and psilocybin in patients with treatment‑resistant depression

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    • TRAZODONE HYDROCHLORIDE
    Italy

  • Efficacy and safety of roluperidone versus drug combination in adults with schizophrenia with negative symptoms

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Aripiprazole
    • Risperidone
    • Fluoxetine Hydrochloride
    Bulgaria Romania

  • Dry extract from Psilocybe cubensis (15‑25:1) with methanol for adults with treatment‑resistant anorexia nervosa: a randomized, active‑placebo, triple‑blind trial

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Anorexia nervosa
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Denmark

  • Effect of Adjunctive Pramipexole on Anhedonia in Adults with Bipolar Depression – Randomized, Double‑Blind, Placebo‑Controlled Phase III Trial

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Pramipexole
    Sweden

  • Evaluation of Trazodone Hydrochloride for Improving Emotional Blunting in Patients with Major Depressive Disorder

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • TRAZODONE HYDROCHLORIDE
    Bulgaria Hungary Poland

  • A Phase 2 Study of Methylenedioxymethamphetamine‑Assisted Therapy in Young Adults (18‑25) with Chronic Treatment‑Resistant Major Depressive Disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Major depression
    Norway
Previous Page
1 … 19 20 21 22 23 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!